News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hepregen Raises First Round


9/3/2008 11:51:39 AM

Hepregen Inc., a Winchester, Mass.-based company focused on reducing the liver toxicity of existing pharmaceuticals, has secured $3 million of a $5 million Series A round, according to a regulatory filing.


comments powered by Disqus
Hepregen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES